Items where authors include "Coleman, RE"

Article

Danson, S, Mulvey, MR orcid.org/0000-0002-6357-3848, Turner, L et al. (6 more authors) (2019) An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain. Journal of Bone Oncology, 19. 100261. ISSN 2212-1374

Walsh, JS, Marshall, H orcid.org/0000-0003-0944-0152, Smith, IL et al. (9 more authors) (2019) Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial. PLOS Medicine, 16 (11). e1002960. ISSN 1549-1277

Tulotta, C, Lefley, DV, Freeman, K et al. (16 more authors) (2019) Endogenous production of IL-1B by breast cancer cells drives metastasis and colonisation of the bone microenvironment. Clinical Cancer Research, 25 (9). pp. 2769-2782. ISSN 1078-0432

Westbrook, JA, Wood, SL, Cairns, DA orcid.org/0000-0002-2338-0179 et al. (14 more authors) (2019) Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer. The Journal of pathology, 247 (3). pp. 381-391. ISSN 0022-3417

Coleman, RE, Collinson, M orcid.org/0000-0003-3568-6455, Gregory, W orcid.org/0000-0003-2641-8416 et al. (20 more authors) (2018) Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04). Journal of Bone Oncology, 13. pp. 123-135. ISSN 2212-1374

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Alberro, JA, Ballester, B et al. (596 more authors) (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. The Lancet Oncology, 19 (1). pp. 27-39. ISSN 1470-2045

Wilson, C, Hinsley, S orcid.org/0000-0001-6903-4688, Marshall, H et al. (4 more authors) (2017) Reproductive hormone analyses and effects of adjuvant zoledronic acid in early breast cancer – an AZURE (BIG 01/04) sub-study. Journal of Bone Oncology, 9. pp. 48-54. ISSN 2212-1374

Westbrook, JA, Cairns, DA orcid.org/0000-0002-2338-0179, Peng, J et al. (10 more authors) (2016) CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment. JNCI: Journal of the National Cancer Institute, 108 (4). ISSN 0027-8874

Kroep, JR, Charehbili, A, Coleman, RE et al. (10 more authors) (2016) Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials. European Journal of Cancer, 54. pp. 57-63. ISSN 0959-8049

Gregory, WM, Twelves, CJ, Bell, R et al. (4 more authors) (2016) Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling. Breast Cancer Research and Treatment, 155 (2). pp. 303-311. ISSN 0167-6806

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Coleman, R, Powles, T et al. (102 more authors) (2015) Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet, 386 (10001). 1353 - 1361. ISSN 0140-6736

Kroep, JR, Charehbili, A, Coleman, RE et al. (10 more authors) (2015) Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials. Cancer Research, 75 (9). Abstract P3-11-04. ISSN 0008-5472

Coleman, RE, Gregory, W, Marshall, H et al. (2 more authors) (2013) The metastatic microenvironment of breast cancer: clinical implications. Breast, 22 S2. S50 - S56. ISSN 0960-9776

Rathbone, EJ, Brown, JE, Marshall, HC et al. (11 more authors) (2013) Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04). Journal of Clinical Oncology, 31 (21). 2685 - 2691. ISSN 1527-7755

Coleman, RE, Marshall, H, Bell, R et al. (1 more author) (2012) Breast-cancer adjuvant therapy with zoledronic acid REPLY. New England Journal of Medicine, 366 (2). 189 - 189. ISSN 0028-4793

Coleman, RE, Marshall, H, Cameron, D et al. (7 more authors) (2011) Breast-cancer adjuvant therapy with zoledronic acid. The New England Journal of Medicine, 365 (15). 1396 - 1405. ISSN 0028-4793

Coleman, RE, Winter, MC, Cameron, D et al. (11 more authors) (2010) The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. British Journal of Cancer, 102 (7). 1099 - 1105. ISSN 0007-0920

Absolom, KL orcid.org/0000-0002-5477-6643, Eiser, C, Michel, G et al. (5 more authors) (2009) Follow-up care for cancer survivors: views of the younger adult. British Journal of Cancer, 101. pp. 561-567. ISSN 0007-0920

Hall, GD orcid.org/0000-0002-8864-5932, Brown, JM orcid.org/0000-0002-2719-7064, Coleman, RE et al. (8 more authors) (2004) Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomised phase III study. British Journal of Cancer, 91 (4). pp. 621-626. ISSN 0007-0920

Adams, M, Calvert, AH, Carmichael, J et al. (20 more authors) (1998) Chemotherapy for ovarian cancer - a consensus statement on standard practice. British Journal of Cancer, 78 (11). pp. 1404-1406. ISSN 0007-0920

Conference or Workshop Item

Stavraka, C, Evans, TRJ, Dunlop, J et al. (6 more authors) (2020) Abstract P2-16-15: 10-year outcome for women randomized in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: An anglo-celtic cooperative oncology group study. In: Abstracts: 2019 San Antonio Breast Cancer Symposium; December 10-14, 2019; San Antonio, Texas, 10-14 Dec 2019, San Antonio, Texas, USA.